Barclays’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Sell |
55,639
-37,600
| -40% | -$114K | ﹤0.01% | 3629 |
|
|
2025
Q1 | $397K | Hold |
93,239
| – | – | ﹤0.01% | 2970 |
|
|
2024
Q4 | $492K | Buy |
+93,239
| New | +$492K | ﹤0.01% | 3062 |
|
|
2022
Q2 | – | Sell |
-2,510
| Closed | -$13K | – | 4909 |
|
|
2022
Q1 | $13K | Buy |
+2,510
| New | +$13K | ﹤0.01% | 4435 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$1K | – | 3703 |
|
|
2015
Q3 | $1K | Sell |
1
-3
| -75% | -$3K | ﹤0.01% | 3756 |
|
|
2015
Q2 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 3921 |
|